Catalyst Crew Technologies Corp.

Catalyst Crew Technologies Corp.

Overview

Catalyst Crew Technologies Corp. is a development-stage technology company focused on research, development, and future commercialization of software-based facial recognition technology (FRT). The company redirected its strategic focus to FRT in 2024 and is evaluating regulatory, privacy, and ethical considerations. It intends to advance toward commercial deployment beginning in 2026, subject to capital and market conditions.

Product, technology, and development status

• Platform: A modular, software-based FRT platform that analyzes facial images and video to identify, verify, or classify individuals using biometric facial features. The architecture supports integration with cameras, databases, and third-party software.
• Development: The technology is under development and was not commercialized in 2025.
• Open-source use: Development combines internally developed software with widely used open-source frameworks and libraries; licensing, security, and compliance are actively managed.

Market and applications

• Target markets: Identity authentication, access control, security monitoring, and analytics for commercial facilities and enterprise environments.
• Deployment options: On-premises and cloud/software-based deployments are contemplated.
• Commercial readiness: Product configurations, pricing, and go-to-market strategies are not finalized; there were no commercial agreements or revenue-producing customers during the reporting period.

Regulatory, privacy, and ethics

• Regulatory: The company is monitoring evolving privacy laws and regulatory oversight and is incorporating data protection and bias-mitigation practices into development.
• Ethics: Management emphasizes transparency, bias mitigation, and responsible use of the technology.

People and operations

• Employees: As of December 31, 2025, the company had no full-time employees and relied on independent contractors to support development and operations.

Facilities

• Principal office: Leased office space at Icon Tower, First Floor, Dubai Internet City, Dubai, United Arab Emirates.
• Rent: Approximately $2,000 per month.

Financial position

• Revenue and customers: No commercial products were available for sale and there were no revenue-generating customer agreements during the period.
• Cash flow and financing: The company had no cash flow from operations and is dependent on external financing (equity offerings, debt, shareholder support) to fund development and potential commercialization.
• Profitability: The company has incurred net losses since inception and expects to continue incurring losses while developing the technology.
• Going concern: The independent auditor issued substantial doubt about the company’s ability to continue as a going concern due to its reliance on future financing.

Recent corporate events

• Change in control and leadership (February–March 2026)
  • February 17, 2026: An affiliate stock purchase resulted in a new controlling shareholder. Dr. Levy acquired 28,000,000 shares from a prior holder for $10,000 and subsequently owned approximately 71.1% of outstanding common stock after additional consideration.
  • February 17, 2026: The company entered an Asset Purchase Agreement with Dr. Levy to acquire an AI-enabled healthcare analytics platform; 12,000,000 restricted shares were issued to Dr. Levy.
  • Following the transactions, Kevin Rodan Levy was appointed Sole Director and to multiple officer roles (CEO, President, CFO, Secretary, Treasurer).
  • February 23–March 2026: Several prior officers and directors resigned (including Andrew Gaudet, Waqas Nakhwa, Navneet B. Tayal, and Vineet Jawa).
• Subsidiary and governance changes (March 2026)
  • March 23, 2026: Acquisition of 100% of Inversiones Long 33, C.A., a Venezuelan operating subsidiary, as part of a Latin American strategy.
  • March 31, 2026: Carlos Peña was appointed Chief Financial Officer.

Notes

The summary reflects disclosures from the company’s annual report excerpt, including forward-looking statements and developments through March 2026.